ChartRow logo
ARGX
argenx SE American Depositary SharesStock · Health Care
$875.30+$7.36 (+0.85%)as of market close, Aug 6, 2026
CompareLLYUNHJNJABBVISRGTMO

ARGX financial statements

The full income statement, balance sheet, and cash-flow statement for argenx SE American Depositary Shares (ARGX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2017-12 32.2M2018-12 36.0M2019-12 42.8M2020-12 47.6M2021-12 51.7M2022-12 55.4M2023-12 59.2M2024-12 60.8M2025-12 61.9M+92.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
35.5M
YoY+254.4%
10.0M
YoY-98.0%
497M
YoY+1105.7%
Cost of revenue
451M
YoY+98.3%
227M
YoY+92.9%
118M
YoY+300.4%
29.4M
Research & development
1.36B
YoY+38.7%
983M
YoY+14.4%
859M
YoY+29.6%
663M
YoY+14.3%
581M
YoY+56.5%
Operating income
1.05B
YoY+4966.6%
-21.7M
YoY+94.9%
-425M
YoY+41.0%
-720M
YoY-106.6%
-349M
YoY+27.0%
Interest expense
4.08M
YoY+65.7%
2.46M
YoY+172.0%
906K
YoY-76.8%
3.91M
YoY-14.7%
4.58M
YoY-42.5%
Pre-tax income
1.28B
YoY+1401.1%
85.2M
YoY+128.0%
-304M
YoY+58.2%
-729M
YoY-82.4%
-400M
YoY+34.0%
Income tax
-13.4M
YoY+98.2%
-748M
YoY-7819.7%
-9.44M
YoY+52.1%
-19.7M
YoY-331.4%
8.52M
YoY+174.6%
1.29B
YoY+55.1%
833M
YoY+382.3%
-295M
YoY+58.4%
-710M
YoY-73.8%
-408M
YoY+32.9%
$19.57
YoY+53.1%
$12.78
YoY+347.7%
-$5.16
YoY+60.5%
-$13.05
YoY-63.3%
-$7.99
YoY+40.4%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
6.90B
YoY+41.3%
4.88B
YoY+18.4%
4.12B
YoY+48.6%
2.77B
YoY+9.1%
2.54B
YoY+23.6%
8.68B
YoY+40.0%
6.20B
YoY+36.5%
4.54B
YoY+44.9%
3.13B
YoY+10.0%
2.85B
YoY+25.0%
Total current liabilities
1.32B
YoY+97.1%
670M
YoY+58.4%
423M
YoY+39.9%
302M
YoY+0.3%
301M
YoY-8.3%
Total liabilities
1.36B
YoY+93.1%
704M
YoY+58.3%
445M
YoY+38.8%
321M
YoY+1.4%
316M
YoY-47.8%
7.32B
YoY+33.2%
5.50B
YoY+34.2%
4.10B
YoY+45.6%
2.81B
YoY+11.0%
2.53B
YoY+51.4%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Cash from operations
685M
YoY+928.1%
-82.7M
YoY+80.3%
-420M
YoY+51.3%
-863M
YoY-42.2%
-607M
YoY-52.3%
Acquisitions
0.00
0.00
0.00
0.00
0.00
Long-term debt issued
0.00
0.00
0.00
0.00
0.00
Long-term debt repaid
0.00
0.00
0.00
0.00
0.00
Common stock issued
0.00
0.00
YoY-100.0%
1.20B
YoY+57.3%
761M
YoY-30.3%
1.09B
YoY+34.2%
Common stock repurchased
0.00
0.00
0.00
0.00
0.00
Dividends paid
0.00
0.00
0.00
0.00
0.00
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
52.0B
YoY+39.3%
37.4B
YoY+77.3%
21.1B
YoY+7.7%
19.6B
YoY+8.2%
18.1B
YoY+29.3%
P/E
40.3×
YoY-10.2%
44.9×
P/S
1464.6×
YoY+39.3%
1051.6×
YoY-50.0%
2102.0×
YoY+5240.2%
39.4×
YoY+8.2%
36.4×
YoY-89.3%
P/B
7.1×
YoY+4.6%
6.8×
YoY-9.3%
7.5×
YoY-3.0%
7.7×
YoY+8.2%
7.1×
YoY-14.6%
2.5%
YoY+11.4%
2.2%
Source filing20-F20-F20-F20-F20-F

About this data

Source: ARGX's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ARGX filings on SEC EDGAR → Not investment advice.